RESUMO
BACKGROUND: Anti-transglutaminase antibodies are highly predictive markers of active coeliac disease. Because limited facilities are available for routine use of anti-transglutaminase antibodies assays in developing countries, a simple, economical immunological test would represent a great step forward in the screening of coeliac disease. AIM: We determined the prevalence of coeliac disease in two different populations living in an urban area and in a sub-urban impoverished area of Recife (Brazil), using two rapid tests based on detection of anti-transglutaminase antibodies in serum and in one drop of whole blood. METHODS: Whole-blood and serum samples from 1074 individuals were analysed by the two rapid tests; 580 subjects were university students and 494 subjects were coming from sub-urban impoverished areas, characterized by the endemic presence of filariasis. The positive subjects were evaluated by anti-tranglutaminase enzyme linked immunosorbent assay (ELISA) assay, the coeliac disease-related HLA DQ2/8 and intestinal biopsy. RESULTS: Both rapid assays were positive in 25/1074 subjects, but only 9/25 (4/4 in urban areas, specificity 100%; 5/21 in poor areas, specificity 76%) were confirmed positive by ELISA assay. The nine subjects testing positive for HLA DQ2 and the intestinal biopsy showed the typical coeliac disease lesions (coeliac disease-prevalence: 0.84%, 9/1074); seven coeliacs were asymptomatic and two presented recurrent abdominal pain. CONCLUSIONS: The rapid assays were accurate in finding new coeliacs at a remarkably low cost. We are convinced that this new way of testing for coeliac disease can be successfully used by non-specialized personnel in daily practice in developing countries.
Assuntos
Anticorpos/análise , Doença Celíaca/diagnóstico , Programas de Rastreamento/métodos , Transglutaminases/imunologia , Adulto , Biópsia , Brasil/epidemiologia , Doença Celíaca/epidemiologia , Doença Celíaca/imunologia , Países em Desenvolvimento , Diagnóstico Diferencial , Ensaio de Imunoadsorção Enzimática , Feminino , Humanos , Incidência , Masculino , Estudos Retrospectivos , População Rural , População UrbanaRESUMO
Patients with celiac disease are at high risk of having autoimmune disorders. Moreover, untreated patients with celiac disease have been found to have a higher than expected prevalence of organ-specific autoantibodies. In a prospective study of 90 patients with celiac disease, we found that the prevalence of diabetes and thyroid-related serum antibodies was 11.1% and 14.4%, respectively. Like antiendomysium autoantibodies, these organ-specific antibodies seem to be gluten-dependent and tend to disappear during a gluten-free diet.
Assuntos
Doença Celíaca/epidemiologia , Diabetes Mellitus Tipo 1/epidemiologia , Glutens/efeitos adversos , Tireoidite Autoimune/epidemiologia , Estudos de Casos e Controles , Doença Celíaca/dietoterapia , Criança , Comorbidade , Diabetes Mellitus Tipo 1/prevenção & controle , Feminino , Humanos , Itália/epidemiologia , Masculino , Prevalência , Estudos Prospectivos , Tireoidite Autoimune/prevenção & controleRESUMO
Serum levels of IgA and IgG antigliadin antibodies were evaluated in 267 subjects by using both the classic enzyme-linked immunosorbent assay and a rapid test (strip-AGA test) performed on a drop of whole blood. This new test was easy to perform and gave results comparable to those of the enzyme-linked immunosorbent assay; it could be useful in screening for celiac disease in both at-risk and normal populations.